“The vaccine saves lives but it will not be a silver bullet,” said Dr. Githinji Gitahi, the chief executive officer for Amref Health Africa, a nongovernmental organization.
The vaccine, called Mosquirix, targets the deadliest malaria parasite and the most common in Africa — Plasmodium falciparum. While the vaccines are a “huge addition to the fight” against malaria, said Dr. Gitahi, health officials will still have to deploy “a Swiss cheese strategy,” which includes insecticide-treated bed nets and indoor spraying.
Faith Walucho is the mother of an 11-month-old who was recently diagnosed with malaria. The 29-year-old trader of used clothing in the city of Kisumu in western Kenya said she received the news about the vaccines “with a lot of happiness.” In Kenya, an estimated 10,700 deaths from malaria are recorded annually, and Kisumu, on the shores of Lake Victoria, is one of the high-malaria regions where the vaccine was tested.
As soon as she’s in a position to get a dose for her daughter, Ms. Walucho stated, “I will run” to get it.
In Malawi’s capital, Lilongwe, Jenala Mwafulirwa, a 52-year-old mom of 5, welcomed the information of the vaccine, saying that too many youngsters in her household had been misplaced to the illness, significantly in rural areas the place entry to well being care is restricted.
“This vaccine has come at the right time,” she stated.
But in some locations, folks voiced skepticism concerning the vaccine, partially due to distrust of the World Health Organization.
“I wonder why they want to help Africa,” stated Mamadou Tounkara, a 40-year-old-teacher in Senegal’s capital, Dakar. He requested why the W.H.O. didn't as an alternative fund higher hygiene and sanitation techniques. “If W.H.O. wants to help eradicate this disease, they can do it without the vaccine.”
Yet public well being officers say the vaccine, which has been in growth for greater than 30 years, has already proved to be an essential weapon within the struggle in opposition to the illness.